source · application/json
source_ec267cc1f01048e6
sha256 7e5825f3e6133eae805d35a4f9189438ad927224ba1f9fc9e61ad98f9c5fcc52
by researka:v2 · 2026-06-25 21:11:00.248691+04:00
{"publication_id": "bbd5ee7e-b2b2-4964-9852-251e96239bf8", "traces": [{"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The evidence profile indicates that the Cancer evidence base shows positive directional signals for contextual other and longevity endpoints (Qi 2026; Svendsen 2026) and negative directional signals for deficiency prevalence and muscle function (Tawengi 2026; Markarian 2026), but the dominant pattern is null with several direct-vs-indirect tensions unresolved, leaving the anti-aging case incomplete and dependent on future trials that report hard, frailty-anchored outcomes rather than biomarker substitution alone.", "claim_id": "claim_1"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "Evidence-abstraction note.** The 42 retained reference papers are not 42 independent primary clinical trials: 34 are review, indirect, mechanistic, or registered-protocol source-level summaries, and 8 are classified as direct interventional evidence.", "claim_id": "claim_2"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The review is organized around the distinction between direct interventional hard-endpoint evidence, indirect interventional hard-endpoint evidence, and mechanistic evidence so that biological plausibility is not confused with clinical certainty.", "claim_id": "claim_3"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The corpus contains 8 direct clinical sources, 34 adjacent clinical sources, and no sources classified primarily as mechanistic or model-system evidence. That distribution makes the synthesis appropriate for evaluating convergence, boundary conditions, and trial-design implications, while requiring caution around any conclusion that would exceed the direct human evidence.", "claim_id": "claim_4"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The thesis is: Across 42 curated reference papers, the evidence base for Cancer shows a context-dependent profile. Positive signals: contextual other, longevity (Qi 2026). Negative signals: deficiency prevalence, muscle function (Markarian 2026). Null findings dominate: contextual other, safety comorbidity. The synthesis surfaces cross-study disagreements across outcome classes — see Cross-Domain Synthesis. The Cancer anti-aging case as currently constituted is incomplete: mechanistic plausibility coexists with mixed or sparse human-RCT evidence, and the boundary conditions remain to be established. This thesis is treated as an organizing claim, not as a substitute for the study table, because the source record includes supportive, null, and adverse signals across different outcome classes.", "claim_id": "claim_5"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "This distinction matters for publication because it makes the paper falsifiable. A future source can strengthen, weaken, or reverse the synthesis by changing the evidence tier, direction, or outcome-class balance.", "claim_id": "claim_6"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The mechanistic layer is most useful when it explains why a trial signal might appear or fail to appear. It is weaker when it is used as a replacement for outcome data, so this synthesis treats it as interpretive support rather than independent clinical proof.", "claim_id": "claim_7"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "Null findings have a specific role in this evidence model. They do not erase mechanistic plausibility, but they do narrow the set of claims that can be made about effect consistency, target population, and endpoint selection.", "claim_id": "claim_8"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "Adverse or negative signals are likewise retained in the main interpretation. For an aging intervention, the risk profile is part of the efficacy question because a plausible mechanism is not sufficient if the same corpus shows offsetting harm or tolerability constraints.", "claim_id": "claim_9"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The evidence base also distinguishes breadth from certainty. A broad corpus can cover many biological domains while still leaving the clinically decisive question unresolved if direct evidence is limited, heterogeneous, or endpoint-specific.", "claim_id": "claim_10"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "This paper synthesizes evidence on cancer biomarker effects across 42 accepted source papers and 1775 high-confidence extracted claims.", "claim_id": "claim_11"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The evidence profile contains 8 direct clinical sources, 34 adjacent clinical sources, and no sources classified primarily as mechanistic or model-system evidence, with a high-density pairwise disagreement map across the evidence base.", "claim_id": "claim_12"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "Positive study-level signals are summarized in the contextual adjacent evidence and longevity outcome classes, null signals in the contextual adjacent evidence, safety and comorbidity, longevity outcome classes, and negative signals in the deficiency prevalence and muscle function outcome classes. The paper therefore interprets the corpus as a tiered evidence profile rather than as a single pooled effect.", "claim_id": "claim_13"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The conclusion is that cancer biomarker effects remains a bounded geroscience case: the retained clinical and adjacent evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim.", "claim_id": "claim_14"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "For that reason, the manuscript does not collapse every source into a single recommendation. It presents the intervention as a set of linked claims whose strength depends on the evidence tier and the match between mechanism, population, and endpoint.", "claim_id": "claim_15"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "This synthesis evaluates evidence on cancer biomarker effects across 42 included source papers and 1775 high-confidence extracted claims.", "claim_id": "claim_16"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "In the introduction section, this principle is applied to the specific evidence-role, endpoint-distance, population-fit, direction-of-effect, and safety-tradeoff pattern in the retained corpus rather than repeated as a generic caution. The section uses that lens to explain why translation remains conditional, which future evidence would change the interpretation, and which claims should remain bounded until direct endpoint evidence is stronger.", "claim_id": "claim_17"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The research question is interpreted through design, population, and endpoint boundaries. Population fit, comparator alignment, clinical directness, follow-up length, ascertainment method, baseline risk, adherence, exposure dose, and external validity are kept separate during interpretation. The interpretation", "claim_id": "claim_18"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The research question is interpreted through design, population, and endpoint boundaries. Cellular mechanism, animal-model response, observational association, pilot-trial signal, randomized evidence, surrogate endpoint behavior, and hard clinical outcomes are treated as different evidentiary layers. The interpretation", "claim_id": "claim_19"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The background evidence for cancer biomarker effects is heterogeneous rather than uniformly confirmatory. Direct clinical sources such as Qi 2026, Gwenzi 2026, Hu 2025 are interpreted separately from mechanistic studies such as the retained evidence base, because these evidence roles answer different questions about aging biology and clinical translation.", "claim_id": "claim_20"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The direct evidence establishes what has been observed in human or adjacent clinical settings. The mechanistic evidence helps explain why an effect might be plausible, but it does not by itself establish the size, durability, or safety of a human healthspan effect.", "claim_id": "claim_21"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "Across the retained sources, positive signals cluster around the contextual adjacent evidence and longevity outcome classes; null signals around the contextual adjacent evidence, safety and comorbidity, longevity outcome classes; and negative or adverse signals around the deficiency prevalence and muscle function outcome classes. This pattern motivates a synthesis that keeps outcome domains separate before drawing cross-domain interpretation.", "claim_id": "claim_22"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The study-level structure also prevents selective emphasis. Supportive, null, mixed, and adverse findings remain visible in the same manuscript, allowing the reader to distinguish evidential breadth from evidential certainty.", "claim_id": "claim_23"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The resulting paper is therefore a calibrated synthesis: it can identify plausible mechanisms, observed direct signals when present, unresolved tensions, and trial-design priorities without converting them into claims stronger than the retained corpus can support.", "claim_id": "claim_24"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "The following fields were extracted from each included source: study design, population / cohort, intervention or exposure, comparator, outcome class, effect direction, effect size, confidence interval or credible interval, p-value, sample size, follow-up duration, risk-of-bias rating. Under the calibration rule, source verification in the public bundle is limited to reference-level metadata; exact statistics and effect directions are drawn from these structured extraction artifacts (the synthesis manifest, risk-of-bias sidecar when populated, and claim registry) rather than from re-parsed full text.", "claim_id": "claim_25"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "Risk-of-bias framework assignment follows study design (RoB-2 for RCTs, ROBINS-I for non-randomised studies, AMSTAR-2 for systematic reviews / meta-analyses). Public appraisal claims are limited to populated `risk_of_bias.json` rows; when no populated ratings are present, interpretation remains bounded by source tier and directness rather than formal RoB certification.", "claim_id": "claim_26"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "Evidence-tension synthesis: claims grouped by outcome class (cardiometabolic, contextual adjacent evidence, deficiency prevalence, frailty, immune and inflammation, longevity, muscle function, safety and comorbidity); within-class agreement, disagreement, and directness gaps surfaced explicitly. Quantitative pooling applied only where ≥3 sources reported a comparable endpoint with extractable effect estimates.", "claim_id": "claim_27"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "Source retrieval, claim extraction, evidence routing, and prose drafting were assisted by large language models under a deterministic audit-trail protocol. Every manuscript claim is traceable to a source record in the supplementary `manifest.json`. Final eligibility and interpretation decisions are author-verified.", "claim_id": "claim_28"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "For cancer biomarker effects, the final interpretation is deliberately tiered: the retained clinical and adjacent evidence profile defines a bounded geroscience rationale, but the corpus does not support treating mechanistic target engagement, intermediate biomarkers, and patient-relevant outcomes as interchangeable evidence. The closing claim should therefore be read as a map of what the retained studies can support, not as a clinical recommendation or a general anti-aging endorsement. Positive signals identify hypotheses and candidate contexts; null, mixed, or adverse signals identify the boundaries that future work must test directly. The evidence hierarchy remains load-bearing here: direct interventional hard-endpoint records carry more interpretive weight than adjacent clinical evidence, and both carry more translational weight than mechanistic or model systems. A stronger future conclusion would require larger direct human samples, prespecified endpoints, longer follow-up, comparable intervention characterization, transparent safety capture, and a consistent direction of effect across clinically proximate outcomes. Until that evidence exists, the paper's conclusion is that the topic is worth structured follow-up only within the boundaries defined by the included source set. That boundary is not a weakness in the paper; it is the main claim that keeps the synthesis reusable. Readers should carry forward the evidence classes separately: favorable mechanistic or surrogate findings can motivate experiments, indirect human findings can prioritize populations and endpoints, and direct clinical findings define the current ceiling for applied interpretation. Pending further trials, the intervention should not be used off-label for geroprotection or anti-aging purposes outside clinical-trial settings given current evidence. Any downstream use should preserve that tiered reading rather than compressing the corpus into a simple yes/no verdict for clinical practice or public messaging.", "claim_id": "claim_29"}, {"candidate_sources": [{"doi": "10.1111/jhn.70205", "study": "Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study", "url": "https://doi.org/10.1111/jhn.70205"}, {"doi": "10.1186/s13643-026-03068-2", "study": "Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis", "url": "https://doi.org/10.1186/s13643-026-03068-2"}, {"doi": "10.1371/journal.pmed.1005111", "study": "Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial", "url": "https://doi.org/10.1371/journal.pmed.1005111"}, {"doi": "10.1093/nutrit/nuaf137", "study": "Long-Term Effectiveness of Dietary Interventions on Inflammatory Biomarkers in Women with Breast Cancer: A Systematic Review and Meta-Analysis", "url": "https://doi.org/10.1093/nutrit/nuaf137"}, {"doi": "10.1016/j.esmoop.2025.105896", "study": "A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study", "url": "https://doi.org/10.1016/j.esmoop.2025.105896"}], "claim": "| Evidence domain | Corpus slice | Strongest signal | Directness | Main limitation |", "claim_id": "claim_30"}]}
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "bbd5ee7e-b2b2-4964-9852-251e96239bf8",
"researka_submission_id": "f4f70b19-d2b8-430d-9694-73b71e9d967f",
"sidecar_name": "citation_traces.json",
"sidecar_url": "https://api.researka.org/publications/bbd5ee7e-b2b2-4964-9852-251e96239bf8/sidecars/citation_traces.json"
}